Simposi
Study, Development And Rationale Use Of Immunopharmacological Agents
26 ottobre 2017 / 17.00-18.30
| 39 |
Inhibitory receptors activation by antibodies on cancer cells: A new immunopharmacological weapon in our arsenal? Francesca Levi-Schaffer (Jerusalem - Israel) |
| 40 |
The emotional side of autoimmune disorders: a new venue for treatment? Fulvio D’Acquisto (London - UK) |
| 41 |
Towards a stratified targeted approach with biologic therapies in rheumatoid arthritis Costantino Pitzalis (London - UK) |
| 42 |
Glucocorticoid-Induced Leucine Zipper (GILZ) as a mediator of Antiinflammatory Effects of Glucocorticoids Carlo Riccardi (Perugia) |